Study Assessing the Contribution of Telemedicine Monitoring in Addition to Standard Follow-up of an Obesity Program
STROBERRY
Prospective, Single-center, Randomized, Open Label Study Assessing the Contribution of Telemedicine Monitoring in Addition to Standard Follow-up, Strengthening an Obesity Program in Berry (FRANCE)
1 other identifier
interventional
116
1 country
1
Brief Summary
STROBERRY Study is a Prospective, monocentric, randomized, open-label study assessing the contribution of telemedicine, in addition to standard follow-up, strengthening an Obesity program in Berry (France). The principal objective is to study the effectiveness of a follow-up reinforced with telemedicine in addition to the standard multidisciplinary annual follow-up on the rate of patients lost to follow-up after initial or second line management in a multidisciplinary bariatric medical program
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Sep 2024
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2023
CompletedFirst Posted
Study publicly available on registry
July 20, 2023
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2030
April 24, 2024
April 1, 2024
5.5 years
July 12, 2023
April 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rates of patients lost to follow up
Rates of patients lost to follow up measured in both arms and compared 4 years after randomization
4 years
Secondary Outcomes (3)
The evolution of quality of life, self-esteem and perceived health compared to baseline
1,2,3 and 4 years
Rate of patients lost to follow-up will be assessed at standard annual visits at 1, 2 and 3 years after randomization
1,2 and 3 years
Change in waist circumference (cm) compared with the baseline measurement will be assessed at standard annual visits at 1, 2, 3 and 4 years after randomization.
1,2,3 and 4 years
Study Arms (2)
Standard multidisciplinary follow-up reinforced with telemedicine
EXPERIMENTALStandard annual multidisciplinary follow-up, reinforced with telemedicine (remote quarterly motivational interviews)
Standard multidisciplinary follow up
NO INTERVENTIONStandard annual multidisciplinary follow-up without telemedicine follow up
Interventions
Remote motivational interview will be in the form of quarterly telephone call (at 3, 6 and 9 months after the start of annual follow up; the patient is seen again at 12 months as part of the annual follow-up) and this for 4 years. It will be performed by medical staff trained in motivational interviewing and who have completed at least 40 hours training in therapeutic education
Eligibility Criteria
You may qualify if:
- Woman or Male aged from 18 to 60 years old included
- Patient in obesity (BMI\> or = 30)
- Patient who has completed a multidisciplinary medical program for obesity management, as a first- or second-line intention (after initial obesity management) at the investigating center
- Affiliation to a social security scheme
- Patient informed of the study and who had signed the informed consent form
- Management of obesity within the framework of an exclusively interventional program, without redirection to a medical program
- Managing obesity as part of a post-operative program
- Pregnant or breastfeeding women
- Patients deprived of liberty
- Patients under legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Elsanlead
Study Sites (1)
Clinique Saint-François
Châteauroux, 36000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2023
First Posted
July 20, 2023
Study Start
September 1, 2024
Primary Completion (Estimated)
March 1, 2030
Study Completion (Estimated)
March 1, 2030
Last Updated
April 24, 2024
Record last verified: 2024-04